De Riva C, Chen S, Virgili F, Frigato F
Centro per le Malattie Endocrine e Metaboliche Ospedale Civile Umberto I, Mestre-Venezia, Italy.
J Endocrinol Invest. 1992 May;15(5):363-7. doi: 10.1007/BF03348754.
Erythrocyte sodium pump is decreased in hyperthyroid patients. We described the effect of untreated hyperthyroidism on Na+K+ATPase activity, ouabain binding sites and intracellular sodium concentration. We found a reduction in Na+K+ATPase activity and in number of ouabain binding sites with a concomitant increase in intracellular sodium. B-blockade therapy failed to restore normal pump activity and sodium concentration, where only thionamide treatment was successful when it was able to decrease free T3.